Skip to main content

15 Result(s)

within Agota Szende Remove this filter

and

  1. No Access

    Article

    An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom

    Novel messenger RNA (mRNA)-based therapies, currently in development, are emerging as a promising potential treatment modality for a broad range of life-threatening and life-limiting inherited liver diseases, ...

    Pablo E. Bretos-Azcona, Matthew Wallace, Murvin Jootun… in Clinical Drug Investigation (2024)

  2. Article

    Open Access

    Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea

    Despite the dynamic treatment landscape for EGFR mutant-positive metastatic non-small cell lung cancer (EGFRm+ mNSCLC), most of the earlier studies have focused on US or Western populations.

    Cliff Molife, Jae Min Cho, Jennifer Lapthorn, Min Ju Kang… in Drugs - Real World Outcomes (2023)

    Download PDF (673 KB) View Article

  3. Article

    Open Access

    Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South Korea

    European, US, Asian and Korean treatment guidelines all recommend sorafenib as first-line systemic therapy in patients with hepatocellular carcinoma (HCC). However, due to the emergence of several new treatmen...

    Diego Novick, Jae Min Cho, Sam Colman, Agota Szende in Drugs - Real World Outcomes (2022)

    Download PDF (956 KB) View Article

  4. Article

    Open Access

    RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design

    Real-world evidence (RWE) is essential for the development of pharmaceutical and medical technologies and informs treatment-related decisions by regulatory agencies, payers, healthcare providers, and patients....

    Andrew D. **a, Caroline P. Schaefer, Agota Szende, Elke Jahn… in Drugs - Real World Outcomes (2019)

    Download PDF (1316 KB) View Article

  5. Book

    Self-Reported Population Health: An International Perspective based on EQ-5D

    Agota Szende, Bas Janssen… (2014)

  6. Article

    Open Access

    Valuation of transfusion-free living in MDS: results of health utility interviews with patients

    This study measured how myelodysplastic syndrome (MDS) patients value transfusion independence (TI), reduced transfusions (RT) and transfusion-dependence (TD) using health utility assessment methodology.

    Agota Szende, Caroline Schaefer, Thomas F Goss… in Health and Quality of Life Outcomes (2009)

    Download PDF (288 KB) View Article

  7. Book Series

    EuroQol Group Monographs

    Volume 2 / 2007

  8. No Access

    Book

    EQ-5D Value Sets

    Inventory, Comparative Review and User Guide

    AGOTA SZENDE, MARK OPPE, NANCY DEVLIN in EuroQol Group Monographs (2007)

  9. No Access

    Chapter

    Introduction

    Governments and healthcare funders worldwide are making increasing use of economic evaluation to inform priority setting in health care. For various reasons, cost benefit analysis is usually rejected in favour...

    Rosalind Rabin, Frank de Charro, Agota Szende in EQ-5D Value Sets (2007)

  10. No Access

    Chapter

    Comparative review of Visual Analogue Scale value sets

    In addition to the Time Trade-Off approach, the Visual Analogue Scale (VAS) has become the other widely used method to elicit preferences for the EQ-5D. Its less demanding nature, easy administration, and favo...

    Mark Oppe, Agota Szende, Frank de Charro in EQ-5D Value Sets (2007)

  11. No Access

    Chapter

    Comparative review of Time Trade-Off value sets

    The Time Trade-Off (TTO) method has played an important role in generating value sets for the EQ-5D. As one of the most widely accepted preference elicitation methods for health states (Torrance, 1986) and the...

    Agota Szende, Mark Oppe, Frank de Charro in EQ-5D Value Sets (2007)

  12. No Access

    Article

    A taxonomy of health utility assessment methods and the role for uncertainty analysis

    Agota Szende, Caroline Schaefer in The European Journal of Health Economics (2006)

  13. No Access

    Article

    Health care provider payment mechanisms in the new EU members of Central Europe and the Baltic states

    Agota Szende… in The European Journal of Health Economics, formerly: HEPAC (2004)

  14. No Access

    Article

    Health care reform in six Central European countries

    This study gives an overview of the health care reform in six Central European countries after the transition from a central planning system to a regulated market economy. We focused on cost containment polici...

    Mark J. C. Nuijten, Agota Szende… in The European Journal of Health Economics,… (2003)

  15. No Access

    Article

    Methodological guidelines for conducting economic evaluation of healthcare interventions in Hungary: a Hungarian proposal for methodology standards

    Ágota Szende, Z. Mogyorósy, N. Muszbek, J. Nagy… in The European Journal of Health Economics (2002)